Professional Documents
Culture Documents
文章推送1 6-1 19
文章推送1 6-1 19
Title: Changes in Intraocular Pressure and Angle Structure after Dilation in Primary
Angle-Closure Suspects with Visually Significant Cataract
Contents: Dilation of primary angle-closure suspects with concurrent visually
significant cataract appears to have a low risk for intraocular pressure spike. Change
in anterior chamber depth was the main factor associated with postdilation pressure
elevation.
题目:明显白内障伴可疑原发闭角型青光眼散瞳后的眼内压及房角变化
内容:对于明显的白内障伴可疑原发闭角可青光眼的患者,散瞳后有较低的眼
压急速上升的风险,前房深度变化是影响散瞳后眼压变化的主要因素。
2.Title: Impact of Intraocular Pressure Control on Rates of Retinal Nerve Fiber Layer
Loss in a Large Clinical Population
Contents: In a longitudinal study involving a large clinical population, stricter
intraocular pressure control reduced the chance of fast structural loss from glaucoma.
These findings may guide clinicians in establishing target pressures in clinical
practice.
题目:大样本临床人群中眼压控制对视网膜神经纤维层丢失率的影响
内容:在一项涉及大样本临床人群的纵向研究中,更严格的眼压控制降低了青
光眼结构的快速丧失。这些发现可以指导临床医生在临床实践中建立目标眼压。
4.Title: HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials
of Brolucizumab for Neovascular Age-Related Macular Degeneration
Contents: At 96 weeks, brolucizumab provides comparable vision gains to aflibercept,
with greater retinal fluid resolution and a high probability of remaining on an every-
12-weeks regimen from weeks 48 to 96.
题目:HAWK 和 HARRIER:Brolucizumab 对新生血管性年龄相关的黄斑变性
的 3 期临床试验的 96 周结果
内容:在 96 周时,brolucizumab 提供了与 aflibercept 相当的视力增益,同时又
很好的视网膜下液吸收以及在 48-96 周中有很大的可能保持每 12 周一次注射方
案。
13.Title: Vision Impairment and Blindness Prevalence in the United States: Variability
of Vision Health Responses across Multiple National Surveys.
Contents: Prevalence rates for vision impairment(VI) increased significantly with
increasing age group, Based on weighted self-reported surveys, we estimated that 24.8
million persons (7.7%) had presenting VI or blindness. Prevalence rates of VI and
blindness obtained from national survey measures varied widely across surveys and
age groups. Additional research is needed to validate the ability of survey self-report
measures of VI and blindness to replicate results obtained through examination by an
eye health professional.
题目:美国视力障碍和失明患病率
内容:随着年龄的增长,VI 的患病率显着增加。根据加权的自我报告调查,我
们估计有 2480 万人(7.7%)出现 VI 或失明。在不同的调查和年龄组中,通过
国家调查方法获得的 VI 和失明患病率差异很大。需要进行更多的研究来验证对
VI 和失明者进行自我报告测量的能力,以确保眼保健专业人员的检查获得的结
果的重复性。